The effect of a peptide-modified thermo-reversible methylcellulose on wound healing and LV function in a chronic myocardial infarction rodent model

Biomaterials

Volumn 34, Issue 35, 2013, Pages 8869-8877

  Mihardja, Shirley S ^a   Gonzales, Jose A ^b   Gao, Dongwei ^a,b   Sievers, Richard E ^b   Fang, Qizhi ^b   Stillson, Carol A ^b   Yu, Jiashing ^a   Peng, Michelle ^b   Lee, Randall J ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Cardiac tissue engineering; Cellulose; Wound healing

Indexed keywords

ANGIOGENESIS; CARDIAC FUNCTIONS; CARDIAC TISSUE ENGINEERING; LEFT VENTRICULAR; LEFT VENTRICULAR FUNCTION; MICROENVIRONMENTS; MYOCARDIAL INFARCTION; WOUND HEALING;

CELL ADHESION; CELLULOSE; DISEASES; ENZYME ACTIVITY; FUNCTIONAL GROUPS; PEPTIDES; POLYMERS; TISSUE ENGINEERING;

CONJUGATED POLYMERS;

ARGINYLGLYCYLASPARTIC ACID; METHYLCELLULOSE; POLYMER;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CHRONIC DISEASE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FLOW KINETICS; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE CELL; ISCHEMIC CARDIOMYOPATHY; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; RAT; WOUND HEALING;

RODENTIA;

ANGIOGENESIS; CARDIAC TISSUE ENGINEERING; CELLULOSE; WOUND HEALING;

ANIMALS; EXTRACELLULAR MATRIX; FEMALE; HEART VENTRICLES; METHYLCELLULOSE; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR FUNCTION, LEFT; WOUND HEALING;

EID: 84883242487     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.07.028     Document Type: Article

References (50)

1. Lenfant C. Fixing the failing heart. Circulation 1997, 95:771-772.
2. National Heart L, and Blood Institute National Institutes of Health Data fact sheet: congestive heart failure in the united states: a new epidemic 2010.
3. Dai W., Wold L.E., Dow J.S., Kloner R.A. Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction. JAm Coll Cardiol 2005, 46:714-719.
4. Jackson B.M., Gorman J.H., Salgo I.S., Moainie S.L., Plappert T., St.John-Sutton M., et al. Border zone geometry increases wall stress after myocardial infarction: contrast echocardiographic assessment. Am J Physiol Heart Circ Physiol 2003, 284:H475-H479.
5. Wall S.T., Walker J.C., Healy K.E., Ratcliffe M.B., Guccione J.M. Theoretical impact of the injection of material into the myocardium. Circulation 2006, 114:2627-2635.
6. Wenk J.F., Wall S.T., Peterson R.C., Helgerson S.L., Sabbah H.N., Burger M., et al. Amethod for automatically optimizing medical devices for treating heart failure: designing polymeric injection patterns. JBiomech Eng 2009, 131:121011-121017.
7. Yu J., Christman K.L., Chin E., Sievers R.E., Saeed M., Lee R.J. Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy. JThorac Cardiovasc Surg 2009, 137:180-187.
8. Lee R.J., Hinson A., Bauernschmidtt R., Sabbah H.N. Polymer-based restoration of left ventricular mechanics. Cell Transplant 2013, 22:529-533.
9. Mihardja S.S., Gao D., Sievers R.E., Fang Q., Feng J., Wang J., et al. Targeted invivo extracellular matrix formation promotes neovascularization in a rodent model of myocardial infarction. PLoS One 2010, 5:e10384.
10. Shimizu T., Yamato M., Isoi Y., Akutsu T., Setomaru T., Abe K., et al. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 2002, 90:e40-e48.
11. Wang C.C., Chen C.H., Lin W.W., Hwang S.M., Hsieh P.C., Lai P.H., et al. Direct intramyocardial injection of mesenchymal stem cell sheet fragments improves cardiac functions after infarction. Cardiovasc Res 2008, 77:515-524.
12. Gupta D., Tator C.H., Shoichet M.S. Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord. Biomaterials 2006, 27:2370-2379.
13. Stabenfeldt S.E., Garcia A.J., LaPlaca M.C. Thermoreversible laminin-functionalized hydrogel for neural tissue engineering. JBiomed Mater Res A 2006, 77:718-725.
14. Stalling S.S., Akintoye S.O., Nicoll S.B. Development of photocrosslinked methylcellulose hydrogels for soft tissue reconstruction. Acta Biomater 2009, 5:1911-1918.
15. Patel S., Tsang J., Harbers G.M., Healy K.E., Li S. Regulation of endothelial cell function by grgdsp peptide grafted on interpenetrating polymers. JBiomed Mater Res A 2007, 83A:423-433.
16. Pierschbacher M., Hayman E.G., Ruoslaht E. Synthetic peptide with cell attachment activity of fibronectin. Proc Natl Acad Sci U S A 1983, 80:1224-1227.
17. Cameron J.D., Skubitz A.P.N., Furcht L.T. Type iv collagen and corneal epithelial adhesion and migration. Invest Ophthalmol Vis Sci 1991, 32:2766-2773.
18. Maldonado B.A., Furcht L.T. Involvement of integrins with adhesion-promoting, heparin-binding peptides of type iv collagen in cultured human corneal epithelial cells. Invest Ophthalmol Vis Sci 1995, 36:364-372.
19. Rowley J.A., Madlambayan G., Mooney D.J. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 1999, 20:45.
20. Ogushi Y., Sakai S., Kawakami K. Synthesis of enzymatically-gellable carboxymethylcellulose for biomedical applications. JBiosci Bioeng 2007, 104:30-33.
21. Larsen C.C., Kligman F., Tang C., Kottke-Marchant K., Marchant R.E. Abiomimetic peptide fluorosurfactant polymer for endothelialization of eptfe with limited platelet adhesion. Biomaterials 2007, 28:3537-3548.
22. Christman K.L., Vardanian A.J., Fang Q., Sievers R.E., Fok H.H., Lee R.J. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. JAm Coll Cardiol 2004, 44:654-660.
23. Christman K.L., Fok H.H., Sievers R.E., Fang Q., Lee R.J. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng 2004, 10:403-409.
24. Huang N.F., Yu J., Sievers R., Li S., Lee R.J. Injectable biopolymers enhance angiogenesis after myocardial infarction. Tissue Eng 2005, 11:1860-1866.
25. Sievers R.E., Schmiedl U., Wolfe C.L., Moseley M.E., Parmley W.W., Brasch R.C., et al. Amodel of acute regional myocardial ischemia and reperfusion in the rat. Magn Reson Med 1989, 10:172-181.
26. Yu J., Gu Y., Du K.T., Mihardja S., Sievers R.E., Lee R.J. The effect of injected rgd modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model. Biomaterials 2009, 30:751-756.
27. Litwin S.E., Katz S.E., Morgan J.P., Douglas P.S. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation 1994, 89:345-354.
28. Springer M.L., Sievers R.E., Viswanathan M.N., Yee M.S., Foster E., Grossman W., et al. Closed-chest cell injections into mouse myocardium guided by high-resolution echocardiography. Am J Physiol Heart Circ Physiol 2005, 289:H1307-H1314.
29. Virag J.I., Murry C.E. Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. Am J Pathol 2003, 163:2433-2440.
30. Genes N.G., Rowley J.A., Mooney D.J., Bonassar L.J. Effect of substrate mechanics on chondrocyte adhesion to modified alginate surfaces. Arch Biochem Biophys 2004, 422:161-167.
31. Rowley J.A., Mooney D.J. Alginate type and rgd density control myoblast phenotype. JBiomed Mater Res 2002, 60:217-223.
32. Evangelista M.B., Hsiong S.X., Fernandes R., Sampaio P., Kong H.-J., Barrias C.C., et al. Upregulation of bone cell differentiation through immobilization within a synthetic extracellular matrix. Biomaterials 2007, 28:3644.
33. Doursout M.F., Wouters P., Kashimoto S., Hartley C.J., Rabinovitz R., Chelly J.E. Measurement of cardiac function in conscious rats. Ultrasound Med Biol 2001, 27:195-202.
34. Nozawa E., Kanashiro R.M., Murad N., Carvalho A.C.C., Cravo S.L.D., Campos O., et al. Performance of two-dimensional doppler echocardiography for the assessment of infarct size and left ventricular function in rats. Braz J Med Biol Res 2006, 39:687-695.
35. Berry M.F., Engler A.J., Woo Y.J., Pirolli T.J., Bish L.T., Jayasankar V., et al. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol 2006, 290:H2196-H2203.
36. Hennessy K.M., Clem W.C., Phipps M.C., Sawyer A.A., Shaikh F.M., Bellis S.L. The effect of rgd peptides on osseointegration of hydroxyapatite biomaterials. Biomaterials 2008, 29:3075.
37. Hersel U., Dahmen C., Kessler H. Rgd modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials 2003, 24:4385.
38. Massia S.P., Hubbell J.A. An rgd spacing of 440nm is sufficient for integrin alpha v beta 3-mediated fibroblast spreading and 140 nm for focal contact and stress fiber formation. JCell Biol 1991, 114:1089-1100.
39. Salinas C.N., Anseth K.S. The enhancement of chondrogenic differentiation of human mesenchymal stem cells by enzymatically regulated rgd functionalities. Biomaterials 2008, 29:2370.
40. Yang F., Williams C.G., Wang D.A., Lee H., Manson P.N., Elisseeff J. The effect of incorporating rgd adhesive peptide in polyethylene glycol diacrylate hydrogel on osteogenesis of bone marrow stromal cells. Biomaterials 2005, 26:5991-5998.
41. Yu J., Du K.T., Fang Q., Gu Y., Mihardja S.S., Sievers R.E., et al. The use of human mesenchymal stem cells encapsulated in rgd modified alginate microspheres in the repair of myocardial infarction in the rat. Biomaterials 2010, 31:7012-7020.
42. Nam J.-O., Kim J.-E., Jeong H.-W., Lee S.-J., Lee B.-H., Choi J.-Y., et al. Identification of the αvβ3 integrin-interacting motif of βig-h3 and its anti-angiogenic effect. JBiol Chem 2003, 278:25902-25909.
43. Nisato R.E., Tille J.C., Jonczyk A., Goodman S.L., Pepper M.S. Αvβ3 and αvβ5 integrin antagonists inhibit angiogenesis invitro. Angiogenesis 2003, 6:105-119.
44. Thiagarajan P., Rippon A.J., Farrell D.H. Alternative adhesion sites in human fibrinogen for vascular endothelial cells. Biochemistry (Mosc) 1996, 35:4169-4175.
45. Simmons M. Integrative signaling in angiogenesis. Mol Cell Biochem 2004, 264:99-102.
46. Seger R., Krebs E. The mapk signaling cascade. FASEB J 1995, 9:726-735.
47. Vinals F., Pouyssegur J. Confluence of vascular endothelial cells induces cell cycle exit by inhibiting p42/p44 mitogen-activated protein kinase activity. Mol Cell Biol 1999, 19:2763-2772.
48. Setty S., Kim Y., Fields G.B., Clegg D.O., Wayner E.A., Tsilibary E.C. Interactions of type iv collagen and its domains with human mesangial cells. JBiol Chem 1998, 273:12244-12249.
49. Senger D.R., Perruzzi C.A., Streit M., Koteliansky V.E., de Fougerolles A.R., Detmar M. The α1β1 and α2β1 integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis. Am J Pathol 2002, 160:195-204.
50. Manohar A., Shome S.G., Lamar J., Stirling L., Iyer V., Pumiglia K., et al. Α3β1 integrin promotes keratinocyte cell survival through activation of a mek/erk signaling pathway. JCell Sci 2004, 117:4043-4054.